VYGR logo
Voyager Therapeutics, Inc.(VYGR)
Last print unknown agoAbout this dataData status
$2.05▲0.15 (7.89%)Stale · unknown old

VYGR EBITDA Margin

-301.17%TTM

Period ending:

VYGR FY EBITDA Margin%
VYGR FY EBITDA Margin202.04%-1314.62%
2013-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

VYGR ebitda margin history

EBITDA as a percentage of revenue. The available annual fiscal periods series contains 13 observations from Dec 31, 2013 to Dec 31, 2025.

Voyager Therapeutics Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-286.1173%
-74.5066%
55.2698%
-96.9174%
-176.4854%
18.2326%
-46.8565%
-1,167.8435%
-693.3202%
-286.1252%
-113.3841%
0%
0%

Compare ebitda margin

All VYGR financial metrics · VYGR stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.